Related references
Note: Only part of the references are listed.Extrastriatal SPECT-DAT uptake correlates with clinical and biological features of de novo Parkinson's disease
Frederic Sampedro et al.
NEUROBIOLOGY OF AGING (2021)
Profiling the Biochemical Signature of GBA-Related Parkinson's Disease in Peripheral Blood Mononuclear Cells
Micol Avenali et al.
MOVEMENT DISORDERS (2021)
Clinical and Dopamine Transporter Imaging Characteristics of Leucine- Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study
Tanya Simuni et al.
MOVEMENT DISORDERS (2020)
Young-onset and late-onset Parkinson's disease exhibit a different profile of fluid biomarkers and clinical features
Tommaso Schirinzi et al.
NEUROBIOLOGY OF AGING (2020)
A common polymorphism in SNCA is associated with accelerated motor decline in GBA-Parkinson's disease
Thomas B. Stoker et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2020)
Glucocerebrosidase Defects as a Major Risk Factor for Parkinson's Disease
Micol Avenali et al.
FRONTIERS IN AGING NEUROSCIENCE (2020)
Evaluating the Role ofSNCA,LRRK2, andGBAin Chinese Patients WithEarly-OnsetParkinson's Disease
Yongping Chen et al.
MOVEMENT DISORDERS (2020)
GBA-RelatedParkinson's Disease: Dissection of Genotype-Phenotype Correlates in a Large Italian Cohort
Simona Petrucci et al.
MOVEMENT DISORDERS (2020)
Extrastriatal dopaminergic and serotonergic pathways in Parkinson's disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study
Andrea Pilotto et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Evolution of prodromal parkinsonian features in a cohort of GBA mutation-positive individuals: a 6-year longitudinal study
Micol Avenali et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
GBA1-associated parkinsonism: new insights and therapeutic opportunities
Emory Ryan et al.
CURRENT OPINION IN NEUROLOGY (2019)
Features of GBA-associated Parkinson's disease at presentation in the UK Tracking Parkinson's study
Naveed Malek et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
The Parkinson's progression markers initiative (PPMI) - establishing a PD biomarker cohort
Kenneth Marek et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2018)
GBA mutations in Parkinson disease: earlier death but similar neuropathological features
C. H. Adler et al.
EUROPEAN JOURNAL OF NEUROLOGY (2017)
Cognitive Impairment in Glucocerebrosidase (GBA)-Associated PD: Not Primarily Associated With Cerebrospinal Fluid Abeta and Tau Profiles
Stefanie Lerche et al.
MOVEMENT DISORDERS (2017)
Cerebrospinal Fluid β-Glucocerebrosidase Activity Is Reduced in Parkinson's Disease Patients
Lucilla Parnetti et al.
MOVEMENT DISORDERS (2017)
Validation of the MDS Research Criteria for Prodromal Parkinson's Disease: Longitudinal Assessment in a REM Sleep Behavior Disorder (RBD) Cohort
Seyed-Mohammad Fereshtehnejad et al.
MOVEMENT DISORDERS (2017)
Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression
Seyed-Mohammad Fereshtehnejad et al.
BRAIN (2017)
Survival and dementia in GBA-associated Parkinson's disease: The mutation matters
Roberto Cilia et al.
ANNALS OF NEUROLOGY (2016)
Synaptic failure and α-synuclein
Laura Calo et al.
MOVEMENT DISORDERS (2016)
Age at onset and Parkinson disease phenotype
Gennaro Pagano et al.
NEUROLOGY (2016)
Imaging analysis of Parkinson's disease patients using SPECT and tractography
Seong-Jin Son et al.
SCIENTIFIC REPORTS (2016)
Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations
Roy N. Alcalay et al.
BRAIN (2015)
Glucocerebrosidase and Parkinson disease: Recent advances
Anthony H. V. Schapira
MOLECULAR AND CELLULAR NEUROSCIENCE (2015)
Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies
Davide Chiasserini et al.
MOLECULAR NEURODEGENERATION (2015)
Effects of aging and gender on striatal and extrastriatal [123I]FP-CIT binding in Parkinson's disease
Valtteri Kaasinen et al.
NEUROBIOLOGY OF AGING (2015)
Mild cognitive impairment with suspected nonamyloid pathology (SNAP) Prediction of progression
Anna Caroli et al.
NEUROLOGY (2015)
Neurodegenerative CSF markers in genetic and sporadic PD: Classification and prediction in a longitudinal study
Kathrin Brockmann et al.
PARKINSONISM & RELATED DISORDERS (2015)
New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression A Prospective Cohort Comparison With Other Phenotypes
Seyed-Mohammad Fereshtehnejad et al.
JAMA NEUROLOGY (2015)
The vulnerable ventral tegmental area in Parkinson's disease
Stephanie L. Alberico et al.
BASAL GANGLIA (2015)
Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease
Karen E. Murphy et al.
BRAIN (2014)
Connectivity-Based Functional Analysis of Dopamine Release in the Striatum Using Diffusion-Weighted MRI and Positron Emission Tomography
Andri C. Tziortzi et al.
CEREBRAL CORTEX (2014)
New experimental and clinical links between the hippocampus and the dopaminergic system in Parkinson's disease
Paolo Calabresi et al.
LANCET NEUROLOGY (2013)
Neuronal vulnerability, pathogenesis, and Parkinson's disease
David Sulzer et al.
MOVEMENT DISORDERS (2013)
Epidemiology and neuropsychiatric manifestations of Young Onset Parkinson's Disease in the United States
A. W. Willis et al.
PARKINSONISM & RELATED DISORDERS (2013)
Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains
Matthew E. Gegg et al.
ANNALS OF NEUROLOGY (2012)
Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies
Joseph R. Mazzulli et al.
CELL (2011)
The Parkinson Progression Marker Initiative (PPMI)
Kenneth Marek et al.
PROGRESS IN NEUROBIOLOGY (2011)
EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version 2
Jacques Darcourt et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
The Identification of Parkinson's Disease Subtypes Using Cluster Analysis: A Systematic Review
Stephanie M. van Rooden et al.
MOVEMENT DISORDERS (2010)
Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease
Juliane Neumann et al.
BRAIN (2009)
Epidemiological, clinical, and genetic characteristics of early-onset parkinsonism
A Schrag et al.
LANCET NEUROLOGY (2006)
Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease - A comparison
Z Walker et al.
NEUROLOGY (2004)
Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?
N Tayebi et al.
MOLECULAR GENETICS AND METABOLISM (2003)
Idiopathic Parkinson's disease:: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen
H Braak et al.
JOURNAL OF NEURAL TRANSMISSION (2003)
Striatal and extrastriatal dysfunction in Parkinson's disease with dementia:: a 6-[18F]fluoro-L-dopa PET study
K Ito et al.
BRAIN (2002)
Parkin ubiquitinates the α-synuclein-interacting protein, synphilin-1:: implications for Lewy-body formation in Parkinson disease
KKK Chung et al.
NATURE MEDICINE (2001)
Share Paper
